{"id":295,"date":"2026-09-27T16:51:26","date_gmt":"2026-09-27T16:51:26","guid":{"rendered":"https:\/\/sachastaliklari.org.tr\/?page_id=295"},"modified":"2026-09-27T20:08:37","modified_gmt":"2026-09-27T20:08:37","slug":"ilac-kullanimlari-ve-ilaca-bagli-sac-kayiplari","status":"publish","type":"page","link":"https:\/\/sachastaliklari.org.tr\/?page_id=295","title":{"rendered":"\u0130la\u00e7 Kullan\u0131mlar\u0131 ve \u0130la\u00e7a Ba\u011fl\u0131 Sa\u00e7 Kay\u0131plar\u0131"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\r\n\r\n \r\n

\r\n \u0130la\u00e7 Kullan\u0131mlar\u0131 ve \u0130la\u00e7 Ba\u011fl\u0131 Sa\u00e7 Kay\u0131plar\u0131\r\n <\/h1>\r\n\r\n \r\n
\r\n \"\u0130la\u00e7\r\n

\u015eekil: Sistemik farmakolojik ajanlar\u0131n k\u0131l folik\u00fcl\u00fc d\u00f6ng\u00fcs\u00fc (Anajen ve Telojen faz) \u00fczerindeki etki mekanizmalar\u0131.<\/p>\r\n <\/div>\r\n\r\n \r\n

\r\n

Farmakolojik Ajanlar ve Sa\u00e7 Folik\u00fcl\u00fc Etkile\u015fimi<\/h3>\r\n

\r\n Bir\u00e7ok sistemik ila\u00e7, k\u0131l k\u00f6klerinin y\u00fcksek metabolik aktivitesini veya h\u00fccre b\u00f6l\u00fcnme d\u00f6ng\u00fcs\u00fcn\u00fc hedef alarak sa\u00e7 d\u00f6k\u00fclmesine yol a\u00e7abilir. Yukar\u0131daki g\u00f6rselde de \u00f6zetlendi\u011fi \u00fczere, bu durum genellikle iki ana mekanizma \u00fczerinden ger\u00e7ekle\u015fir: Do\u011frudan h\u00fccre b\u00f6l\u00fcnmesini durd\u0131ran Anajen Effluvium<\/em> veya sa\u00e7lar\u0131 erken dinlenme evresine zorlayan Telojen Effluvium<\/em>.\r\n <\/p>\r\n <\/div>\r\n\r\n \r\n

\r\n

S\u0131k Kar\u015f\u0131la\u015f\u0131lan \u0130la\u00e7 Gruplar\u0131 ve Sa\u00e7 D\u00f6k\u00fclme T\u00fcrleri<\/h3>\r\n
\r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n
\u0130la\u00e7 S\u0131n\u0131f\u0131 \/ Etken Madde Grubu<\/th>\r\n D\u00f6k\u00fclme Tipi<\/th>\r\n Klinik \u00d6zellik ve Ba\u015flang\u0131\u00e7 S\u00fcresi<\/th>\r\n <\/tr>\r\n <\/thead>\r\n
Kemoterap\u00f6tikler (Sitotoksik Ajanlar)<\/td>\r\n Anajen Effluvium<\/td>\r\n H\u0131zl\u0131 h\u00fccre b\u00f6l\u00fcnmesini durdurur; tedaviden g\u00fcnler\/haftalar sonra ani ve \u015fiddetli d\u00f6k\u00fclme g\u00f6r\u00fcl\u00fcr.<\/td>\r\n <\/tr>\r\n
Antikoag\u00fclanlar (Kan Suland\u0131r\u0131c\u0131lar: Heparin, Varis vb.)<\/td>\r\n Telojen Effluvium<\/td>\r\n Sa\u00e7lar\u0131 erken dinlenme evresine sokar; genellikle ila\u00e7 ba\u015fland\u0131ktan 2-4 ay sonra yayg\u0131n d\u00f6k\u00fclmeyle ba\u015flar.<\/td>\r\n <\/tr>\r\n
Retinoidler (A Vitamini T\u00fcrevleri: \u0130zotretinoin vb.)<\/td>\r\n Telojen Effluvium<\/td>\r\n Doz ba\u011f\u0131ml\u0131 olarak sa\u00e7 siklusunu h\u0131zland\u0131r\u0131r; tedavi s\u00fcrecinde diff\u00fcz seyrelme yapabilir.<\/td>\r\n <\/tr>\r\n
Antikonv\u00fclzanlar ve Duygu Durum D\u00fczenleyiciler<\/td>\r\n Telojen Effluvium<\/td>\r\n Valproik asit ve benzeri ajanlar uzun s\u00fcreli kullan\u0131mda kronik sa\u00e7 seyreltmesine yol a\u00e7abilir.<\/td>\r\n <\/tr>\r\n
Tiroid \u0130la\u00e7lar\u0131 \/ Hormonal Ajanlar<\/td>\r\n Telojen Effluvium<\/td>\r\n Doz ayarlamas\u0131 d\u00f6nemlerinde veya ani hormon de\u011fi\u015fimlerinde ge\u00e7ici sa\u00e7 kay\u0131plar\u0131 tetiklenebilir.<\/td>\r\n <\/tr>\r\n
Beta Blokerler ve Tansiyon \u0130la\u00e7lar\u0131<\/td>\r\n Telojen Effluvium<\/td>\r\n Nadir olmakla birlikte baz\u0131 kardiyovask\u00fcler ajanlar sa\u00e7 folik\u00fcl\u00fc d\u00f6ng\u00fcs\u00fcn\u00fc erkene \u00e7ekebilir.<\/td>\r\n <\/tr>\r\n <\/tbody>\r\n <\/table>\r\n <\/div>\r\n <\/div>\r\n\r\n \r\n
\r\n

\r\n Hastalar\u0131m\u0131z \u0130\u00e7in Bilgilendirme Rehberi\r\n <\/h2>\r\n \r\n

Kulland\u0131\u011f\u0131m \u0130la\u00e7 Sa\u00e7 D\u00f6ker mi?<\/h3>\r\n

Bir\u00e7ok re\u00e7eteli veya re\u00e7etesiz ila\u00e7 sa\u00e7 d\u00f6k\u00fclmesine neden olabilir. Bu durum genellikle iki \u015fekilde kar\u015f\u0131m\u0131za \u00e7\u0131kar: Kemoterapi gibi ila\u00e7lar\u0131n yol a\u00e7t\u0131\u011f\u0131 ani durdurucu d\u00f6k\u00fclmeler (Anajen Effluvium) veya tansiyon, kan suland\u0131r\u0131c\u0131 ya da akne ila\u00e7lar\u0131n\u0131n birka\u00e7 ay sonra tetikledi\u011fi yayg\u0131n d\u00f6k\u00fclmeler (Telojen Effluvium).<\/p>\r\n\r\n

\u0130la\u00e7 D\u00f6k\u00fclmesi Kal\u0131c\u0131 m\u0131d\u0131r?<\/h3>\r\n

Halk aras\u0131nda bilinenin aksine, ila\u00e7lara ba\u011fl\u0131 sa\u00e7 d\u00f6k\u00fclmelerinin \u00e7ok b\u00fcy\u00fck bir k\u0131sm\u0131 ge\u00e7icidir<\/strong>. \u0130la\u00e7 kesildikten veya v\u00fccuttan tamamen at\u0131ld\u0131ktan sonra sa\u00e7 d\u00f6ng\u00fcs\u00fc kendili\u011finden normale d\u00f6ner ve sa\u00e7lar yeniden \u00e7\u0131kmaya ba\u015flar.<\/p>\r\n\r\n

Kritik Uyar\u0131: Asla \u0130lac\u0131n\u0131z\u0131 Kendiniz B\u0131rakmay\u0131n!<\/h3>\r\n

E\u011fer sa\u00e7 d\u00f6k\u00fclmenizin kulland\u0131\u011f\u0131n\u0131z bir ila\u00e7tan kaynakland\u0131\u011f\u0131ndan \u015f\u00fcpheleniyorsan\u0131z, asla doktorunuza dan\u0131\u015fmadan ilac\u0131n\u0131z\u0131 kesmeyin veya de\u011fi\u015ftirmeyin<\/strong>. Tedavinizi y\u00fcr\u00fcten hekiminizle g\u00f6r\u00fc\u015ferek alternatif g\u00fcvenli se\u00e7enekleri de\u011ferlendirebilirsiniz.<\/p>\r\n <\/div>\r\n\r\n \r\n

\r\n

\r\n Hekimler dan Uzmanlar \u0130\u00e7in Klinik Protokol\r\n <\/h2>\r\n \r\n

Klinik Trikoloji Protokol\u00fc: \u0130la\u00e7 Ba\u011fl\u0131 Alopesi Y\u00f6netimi<\/p>\r\n\r\n